The Conclusion presented that HCC patients with higher expression levels of NAP1L1 had a poorer prognosis than those with lower expression levels, and NAP1L1 is an independent prognostic factor for HCC. This evidence concerns the gene NAP1L1 and hepatocellular carcinoma.